Ascendia Pharmaceuticals, Inc.

CIK 1855888 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ascendia Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jul 24, 2026D0001855888-26-000005
Jun 4, 2025D0001855888-25-000001
Oct 11, 2024D0001855888-24-000001
Jul 13, 2022D0001855888-22-000002
Apr 20, 2021D0001855888-21-000001